BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Domantis Limited 

Granta Park

Abington  Cambridge  CB1 6GS  United Kingdom
Phone: 44-1223-896700 Fax: 44-1223-896701


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Ablynx Wins Patent Opposition Case Against Domantis Limited (GlaxoSmithKline (GSK)) 2/11/2010 11:44:29 AM
Ablynx And Domantis Limited Settle Their Dispute And Stop The Arbitration Process 10/12/2009 10:25:42 AM
Ablynx Responds to Request for Arbitration from Domantis Limited 2/5/2008 10:19:35 AM
Arana Therapeutics Announces Final Receipt of $17.7 Million from Sale of Domantis Limited 1/10/2008 6:53:18 AM
Peptech Limited Announces Acquisition By GlaxoSmithKline (GSK) Of Domantis Limited Completed 1/8/2007 3:14:07 PM
Domantis Limited First To Win UK Innovation In Drug Discovery & Development Award 7/13/2006 10:18:23 AM
Gregory Perry Joins Domantis Limited As CFO 6/28/2006 11:06:37 AM
Domantis Granted Broad European Patent Rights To Pioneering Half-Life Extension Technology 6/20/2006 10:57:40 AM
Domantis Limited Raises $29 Million In Series B Financing 12/12/2005 11:01:36 AM
Domantis Limited' Dual Targeting Domain Antibodies Shown To Kill Multiple Myeloma Cells And Spare Healthy Cells 12/7/2005 11:19:23 AM
12